Gerald S. Falchook, MD, MS
Director, Drug Development
Dr. Falchook completed his oncology training at MD Anderson Cancer Center, where he also served as a faculty member for six years, developing investigator-initiated clinical trials, as well as collaborating with pharma/biotech industry partners to bring promising new drugs to cancer patients.
Dr. Falchook has been the principal investigator or co-investigator of more than 160 clinical studies, including the first-in-human studies and regimens that have received FDA approval. His research has been published extensively, with more than 90 publications in peer-reviewed journals, as well as more than 150 abstracts at national and international conferences.